Scilex Holding Company(SCLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SCLX Scilex Holding Company

Market Closed 05-17 16:00:00 EDT

0.9000

+0.0300

+3.45%

盘后0.9699

+0.0699+7.77%

19:59 EDT

High0.9700	Low0.8500	Vol1.12M
Open0.8800	D1 Closing0.8700	Amplitude13.79%
Mkt Cap162.90M	Tradable Cap107.10M	Total Shares181.00M
T/O1.02M	T/O Rate0.94%	Tradable Shares119.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"SCLX","market":"US","secType":"STK","nameCN":"Scilex Holding Company","latestPrice":0.9,"timestamp":1715976000000,"preClose":0.87,"halted":0,"volume":1120274,"hourTrading":{"tag":"盘后","latestPrice":0.9699,"preClose":0.9,"latestTime":"19:59 EDT","volume":53502,"amount":51091.2202,"timestamp":1715990376056},"delay":0,"floatShares":119000000,"shares":181000000,"eps":-1.281493,"marketStatus":"Market Closed","change":0.03,"latestTime":"05-17 16:00:00 EDT","open":0.88,"high":0.97,"low":0.85,"amount":1016899.3723212,"amplitude":0.137931,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.281493,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1716192000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.87,"preHourTrading":{"tag":"盘前","latestPrice":0.86,"preClose":0.87,"latestTime":"09:20 EDT","volume":462,"amount":397.35618846,"timestamp":1715952044330},"postHourTrading":{"tag":"盘后","latestPrice":0.9699,"preClose":0.9,"latestTime":"19:59 EDT","volume":53502,"amount":51091.2202,"timestamp":1715990376056},"volumeRatio":1.714965847215692},"requestUrl":"/m/hq/s/SCLX","defaultTab":"news","newsList":[{"id":"2435757514","title":"Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2435757514","media":"MT Newswires","top":-1,"share":"https://ttm.financial/m/news/2435757514?lang=en_us&edition=fundamental","pubTime":"2024-05-14 22:01","pubTimestamp":1715695299,"startTime":"0","endTime":"0","summary":"Scilex Holding  said Tuesday the US District Court for the District of Delaware approved the settlement between the company, its subsidiary Scilex Pharmaceuticals, and Takeda Pharmaceuticals, resolving a patent infringement lawsuit related to potential gout treatment Gloperba.The company said the US Federal Trade Commission and US Department of Justice's 45-day review period for the settlement has ended.Takeda filed a patent infringement lawsuit against Scilex in November 2023 after Scilex filed a supplemental new drug application with the US Food and Drug Administration to expand the label for Gloperba, its liquid colchicine product.Scilex Holding said Tuesday the agreement also grants Scilex and its affiliates a non-exclusive license to certain Takeda patents under undisclosed terms.Scilex Pharmaceutical has submitted a copy of the consent judgment to the US Food and Drug Administration, aiming to convert tentative approval for Gloperba's label expansion into final approval, Scilex a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scilex-holding-says-federal-court-140139795.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435154785","title":"BRIEF-Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2435154785","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2435154785?lang=en_us&edition=fundamental","pubTime":"2024-05-14 21:24","pubTimestamp":1715693051,"startTime":"0","endTime":"0","summary":"May 14  - Scilex Holding Co   :   * SCILEX HOLDING COMPANY ANNOUNCES FINAL COURT APPROVAL OF A SETTLEMENT AGREEMENT WITH TAKEDA PHARMACEUTICALS TO RESOLVE THE PARAGRAPH IV PATENT INFRINGEMENT LAWSUIT RELATING TO SCILEX’S INTENT TO EXPAND THE LABEL FOR ITS FDA-APPROVED LIQUID COLCHICINE PRODUCT, GLOPERBASource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435454577","title":"SCLX Grows Revenue and Expands Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2435454577","media":"Zacks Small Cap Research","top":-1,"share":"https://ttm.financial/m/news/2435454577?lang=en_us&edition=fundamental","pubTime":"2024-05-14 20:27","pubTimestamp":1715689620,"startTime":"0","endTime":"0","summary":"Scilex Holding Company  is a revenue-generating company that is focused on addressing one of the biggest issues facing humanity today—that of the overuse of opioids. Scilex is focused on developing non-opioid pain management products that provide the relief patients so desperately need, while avoiding the debilitating addiction that often comes with the use of opioids. Roughly 112,000 Americans died in 2023 from overdoses and there we have no doubt that a good number of those involved opioid use at some point to reduce physical pain of various types.Scilex continues to grow its product offerings and distribution channels, leading to more patients being helped and more revenue coming in.The company has three products on the market right now, which we’ve discussed in previous reports, but Scilex also has three treatments in the pipeline that we believe are as important, if not more so, than the company’s current commercialized portfolio.SP-102, or Semdexa, is on track to become the first","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sclx-grows-revenue-expands-portfolio-122700560.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435766320","title":"Scilex Holding Alerts Shareholders of Manipulative Trading Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2435766320","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435766320?lang=en_us&edition=fundamental","pubTime":"2024-05-13 21:12","pubTimestamp":1715605933,"startTime":"0","endTime":"0","summary":"Scilex Holding Company (SCLX) has issued an announcement. Scilex Holding Company has alerted its shareholders about potential manipulative and nake...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scilex-holding-alerts-shareholders-of-manipulative-trading-concerns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scilex-holding-alerts-shareholders-of-manipulative-trading-concerns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2435320896","title":"Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2435320896","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2435320896?lang=en_us&edition=fundamental","pubTime":"2024-05-13 13:00","pubTimestamp":1715576400,"startTime":"0","endTime":"0","summary":"Scilex management is determined to enhance its stockholders’ value and protect their stockholder rights, and is taking steps to combat manipulative and naked short selling practices in Scilex common s","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/13/2880498/0/en/Scilex-Holding-Company-Provides-Information-to-Scilex-Stockholders-Regarding-Manipulative-and-Naked-Short-Selling-of-Scilex-Common-Stock.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430256494","title":"Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2430256494","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2430256494?lang=en_us&edition=fundamental","pubTime":"2024-04-25 20:01","pubTimestamp":1714046460,"startTime":"0","endTime":"0","summary":"PALO ALTO, Calif., April  25, 2024  (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/04/25/2870033/0/en/Scilex-Holding-Company-Announces-Closing-of-15-Million-Registered-Direct-Offering.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430499984","title":"It's Down 33% But Scilex Holding Company (NASDAQ:SCLX) Could Be Riskier Than It Looks","url":"https://stock-news.laohu8.com/highlight/detail?id=2430499984","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2430499984?lang=en_us&edition=fundamental","pubTime":"2024-04-25 03:59","pubTimestamp":1713988751,"startTime":"0","endTime":"0","summary":"The Scilex Holding Company ( NASDAQ:SCLX ) share price has fared very poorly over the last month, falling by a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sclx/scilex-holding/news/its-down-33-but-scilex-holding-company-nasdaqsclx-could-be-r","is_publish_highlight":false,"gpt_icon":0},{"id":"2429905430","title":"Scilex falls on direct offering to raise $15M","url":"https://stock-news.laohu8.com/highlight/detail?id=2429905430","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429905430?lang=en_us&edition=fundamental","pubTime":"2024-04-24 20:14","pubTimestamp":1713960867,"startTime":"0","endTime":"0","summary":"Scilex  stockfell 3.8%in pre-market trade, after it said it is looking to raise $15M through a direct offering of 15M shares of its common stock and warrants.The company set the purchase price at $1.00 per share of common stock and accompanying warrant to purchase one share of common stock.The warrants will have an exercise price of $1.10 per share.More on Scilex Holding Company  Scilex to reduce R&D expenses in 2024, comments on actions post Change Healthcare cyberattack Sorrento wins DoJ’s venue-based challenge to bankruptcy filing","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4093070-scilex-falls-on-direct-offering-to-raise-15m","is_publish_highlight":false,"gpt_icon":0},{"id":"2429437729","title":"BRIEF-Scilex Holding Company Announces $15 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2429437729","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2429437729?lang=en_us&edition=fundamental","pubTime":"2024-04-24 20:10","pubTimestamp":1713960630,"startTime":"0","endTime":"0","summary":"April 24 (Reuters) - Scilex Holding Co   :   * SCILEX HOLDING COMPANY ANNOUNCES $15 MILLION REGISTERED DIRECT OFFERINGSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429437529","title":"Press Release: Scilex Holding Company Announces $15 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2429437529","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2429437529?lang=en_us&edition=fundamental","pubTime":"2024-04-24 20:00","pubTimestamp":1713960000,"startTime":"0","endTime":"0","summary":"PALO ALTO, Calif., April 24, 2024  -- Scilex Holding Company , an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 15,000,000 shares of its common stock, par value $0.0001 per share, and warrants to purchase up to an aggregate of 15,000,000 shares of common stock, at a purchase price of $1.00 per share of common stock and accompanying warrant to purchase one share of common stock, in a registered direct offering. The warrants will have an exercise price of $1.10 per share, will become exercisable on the six month anniversary from the date of issuance and will expire on the date that is five years after the date of issuance.Rodman & Renshaw LLC is acting as the exclusive placement agent for the offering.This press release ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2427822304","title":"Scilex to reduce R&D expenses in 2024, comments on actions post Change Healthcare cyberattack","url":"https://stock-news.laohu8.com/highlight/detail?id=2427822304","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2427822304?lang=en_us&edition=fundamental","pubTime":"2024-04-16 21:14","pubTimestamp":1713273255,"startTime":"0","endTime":"0","summary":"Scilex Holding Company (NASDAQ:SCLX) provided certain preliminary sales for ZTlido in Q1, 2024, and proposed plans to reduce research and development and other administrative expenses in 2024. The com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4090033-scilex-to-reduce-rd-expenses-in-2024-comments-on-actions-post-change-healthcare-cyberattack","is_publish_highlight":false,"gpt_icon":0},{"id":"2427824748","title":"Scilex Holding Preliminary Q1 Net Sales For ZTlido Were $12M-$13M; Q1 Gross Sales For ZTlido Were $34M-$38M; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2427824748","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2427824748?lang=en_us&edition=fundamental","pubTime":"2024-04-16 21:08","pubTimestamp":1713272889,"startTime":"0","endTime":"0","summary":"Scilex Holding Company (NASDAQ:SCLX, &#34;Scilex&#34; or &#34;Company&#34;)))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/24/04/38270068/scilex-holding-preliminary-q1-net-sales-for-ztlido-were-12m-13m-q1-gross-sales-for-ztlido-were-34","is_publish_highlight":false,"gpt_icon":0},{"id":"2426197001","title":"BRIEF-Scilex Launches Co-Pay Programs For ZTlido, ELYXYB","url":"https://stock-news.laohu8.com/highlight/detail?id=2426197001","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2426197001?lang=en_us&edition=fundamental","pubTime":"2024-04-09 21:59","pubTimestamp":1712671188,"startTime":"0","endTime":"0","summary":"April 9  - Scilex Holding Co   :   * SCILEX HOLDING CO: LAUNCHING OF CO-PAY PROGRAMS FOR BOTH ZTLIDO AND ELYXYB FOR COMMERCIALLY INSURED PATIENTS   * SCILEX HOLDING CO: CO-PAY PROGRAMS FOR ZTLIDO & ELYXYB WITH OUT-OF-POCKET COSTS FOR COMMERCIALLY INSURED PATIENTS CAPPED AT $25 MONTHLY   * SCILEX HOLDING CO: ON APRIL 1, A MULTI-STATE MEDICAID PHARMACEUTICAL PURCHASING GROUP ADDED ELYXYB TO ITS PURCHASING POOLSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426199029","title":"Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool","url":"https://stock-news.laohu8.com/highlight/detail?id=2426199029","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2426199029?lang=en_us&edition=fundamental","pubTime":"2024-04-09 13:00","pubTimestamp":1712638800,"startTime":"0","endTime":"0","summary":"Launching Co-Pay programs for ZTlido and ELYXYB for commercially insured patientsMulti-State Medicaid Pharmaceutical Purchasing Group added ELYXYB to its purchasing pool PALO ALTO, Calif., April  09, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/04/09/2860032/0/en/Scilex-Holding-Company-Announces-Launching-of-Co-Pay-Programs-for-Both-ZTlido-and-ELYXYB-for-Commercially-Insured-Patients-and-the-addition-of-ELYXYB-to-a-Multi-State-Medicaid-Phar.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422046991","title":"BRIEF-Scilex Holding Says US Bankruptcy Court Extended Lockup Period On Shares Of Scilex Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2422046991","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2422046991?lang=en_us&edition=fundamental","pubTime":"2024-03-27 21:11","pubTimestamp":1711545092,"startTime":"0","endTime":"0","summary":"March 27  - Scilex Holding Co   :   * SCILEX HOLDING COMPANY ANNOUNCES THAT THE U.S. BANKRUPTCY COURT HAS EXTENDED THE LOCKUP PERIOD ON SHARES OF SCILEX STOCK PREVIOUSLY DISTRIBUTED BY SORRENTO TO ITS STOCKHOLDERS AS A DIVIDENDSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422990459","title":"Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2422990459","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2422990459?lang=en_us&edition=fundamental","pubTime":"2024-03-27 13:00","pubTimestamp":1711515600,"startTime":"0","endTime":"0","summary":"PALO ALTO, Calif., March  27, 2024  (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/03/27/2853239/0/en/Scilex-Holding-Company-Announces-that-the-U-S-Bankruptcy-Court-has-Extended-the-Lockup-Period-on-Shares-of-Scilex-Stock-Previously-Distributed-by-Sorrento-to-its-Stockholders-as-a-.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scilexholding.com","stockEarnings":[{"period":"1week","weight":0.2074},{"period":"1month","weight":-0.2308},{"period":"3month","weight":-0.5187},{"period":"6month","weight":-0.1589},{"period":"1year","weight":-0.8696},{"period":"ytd","weight":-0.5588}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Scilex Holding Company, a biopharmaceutical company, focuses on acquiring, developing, and commercializing non-opioid management products for the treatment of acute and chronic pain. It offers ZTlido, a prescription lidocaine topical product for the relief of neuropathic pain related with postherpetic neuralgia, which is a form of post-shingles nerve pain. The company also develops SP-102, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase III clinical trial to treat lumbosacral radicular pain; SP-103, which is in Phase II clinical trial for the treatment of low back pain; and SP-104 (4.5 mg), a novel low-dose delayed-release naltrexone hydrochloride formulation that has completed Phase I clinical trial for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.262115},{"month":2,"riseRate":1,"avgChangeRate":0.161478},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.115549},{"month":4,"riseRate":0.25,"avgChangeRate":-0.143599},{"month":5,"riseRate":0.5,"avgChangeRate":-0.0311},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.020289},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.002031},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.156476},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.170386},{"month":10,"riseRate":1,"avgChangeRate":0.115495},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.298851},{"month":12,"riseRate":0.333333,"avgChangeRate":0.172459}],"exchange":"NASDAQ","name":"Scilex Holding Company","nameEN":"Scilex Holding Company"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Scilex Holding Company(SCLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Scilex Holding Company(SCLX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Scilex Holding Company,SCLX,Scilex Holding Company股票,Scilex Holding Company股票老虎,Scilex Holding Company股票老虎国际,Scilex Holding Company行情,Scilex Holding Company股票行情,Scilex Holding Company股价,Scilex Holding Company股市,Scilex Holding Company股票价格,Scilex Holding Company股票交易,Scilex Holding Company股票购买,Scilex Holding Company股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Scilex Holding Company(SCLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Scilex Holding Company(SCLX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction